Centene taps veteran insurance exec to lead Wellcare unit

2024-01-22
高管变更
Centene taps veteran insurance exec to lead Wellcare unit
Preview
来源: FierceHealthcare
Carson succeeds Richard Fisher, who will shift to the Operations Team at Centene, reporting to Chief Operating Officer Susan Smith.
Centene has named a new chief executive to lead its Wellcare arm.
Michael Carson" data-entity-type="media" data-entity-uuid="3fecae7e-ae36-44c6-bbb2-9a4cf12f3fb1" data-view-mode="half_body_width"/>
Michael Carson will step into the role of president and CEO of Wellcare, reporting to Ken Fasola, president of Centene. He takes on the title with nearly 30 years of industry leadership experience, the insurer said.
This includes stints at CareAbout, Bright Health Plan and Harvard Pilgrim Health Care, according to an announcement from Centene. He also played a key role in forming and rebuilding the Medicare units at both Amerigroup and Anthem, Centene said.
"We are excited for Michael to join the team and look forward to leveraging his extensive knowledge and expertise for the benefit of our Medicare business," Centene CEO Sarah London said in the press release. "He will be a strong addition to the Wellcare team and its efforts to advance the health of the members we serve."
Carson succeeds Richard Fisher, who will shift to the Operations Team at Centene, reporting to Chief Operating Officer Susan Smith. As part of that team, Fisher will take on "key financial and operational processes across Shared Services," Centene said, as well as take the lead on managing vendor relationships and enterprise development projects.
"I am also excited that we will benefit from Rich's deep Medicare expertise as we continue to fortify our core service operations and build a partner ecosystem to best serve our members across our lines of business," London said.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。